je.st
news
Tag: patient
Under-Body Patient Warming System is safe and effective.
2016-01-14 14:31:06| Industrial Newsroom - All News for Today
Always on and able to be used throughout all perioperative phases, VitaHEAT™ UB3 safely and effectively uses conductive ink technology in thin mattress design. Independent heating zones promote consistent control of warming surface, and design allows full access to surgical sites. Battery and plug-in AC options are available. In addition to being flexible, cleanable, and portable, this reusable solution meets all FDA safety guidelines and has 501(k) clearance.
Tags: system
effective
safe
patient
Be patient with the corn market
2016-01-05 23:25:00| Corn & Soybean Digest
As a producer, I still believe we could see another leg lower in price, but doubt the trade makes many bold moves until it fully digests the USDA end-of-year data scheduled for release on January 12. Grain Market Viewpoint read more
New Initiative shares patient preference study best practices.
2015-12-14 14:31:09| Industrial Newsroom - All News for Today
Initiative launched by BIO and Parent Project Muscular Dystrophy (PPMD) will share best practices for development of disease-specific patient preference studies. Via “BRAVE-rare diseases” (Benefit Risk Assessment, Valuation and Epidemiology for rare diseases), BIO and PPMD will produce one document outlining key considerations to guide stakeholders on development of patient preference studies. This can be used for multiple purposes, including informing drug development and regulatory processes.
Tags: study
practices
patient
shares
Plastics Color And Fitsi Collaborate To Produce Antimicrobial Bedside Caddy Designed To Improve Patient Hygiene
2015-12-03 11:31:12| Industrial Newsroom - All News for Today
CHICAGO, IL In hospital environments, proper hand hygiene is crucial to prevent the transfer of dangerous bacteria. Per the Center for Disease Control and Prevention, an estimated 275 patients die daily from hospital-acquired infections, in part due to the transfer of bacteria via unclean hands. Annually, two...
Tags: designed
color
improve
produce
Celyad Treats First Patient of Second Cohort in NKG2D Car T-Cell Phase I Trial
2015-12-01 07:59:13| Semiconductors - Topix.net
Celyad , a leader in the discovery and development of engineered cell therapies, with clinical programs in cardiovascular disease and immuno-oncology, today announced the infusion of the first patient of the second cohort of its Phase I clinical trial evaluating the Company's NKG2D CAR T-Cell therapy in acute myeloid leukaemia and multiple myeloma indications. Dr. Christian Homsy, CEO of Celyad, said : " The treatment of the first patient enrolled in the second cohort of our first-in-man Phase I trial evaluating NKG2D CAR T-Cells demonstrates continued progress in developing our lead immune-oncology program.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] next »